Page 225 - Developing News Today

HBO Max has officially ordered a spinoff series about The Penguin, with Colin Farrell reprising his role as underworld kingpin Oswald Cobblepot from the recently released film The Batman.

China looks forward to seeing emerging markets and developing countries playing a bigger and more active role in global governance in the future, State Councilor and Foreign Minister Wang Yi said at a news conference on Monday.

China looks forward to seeing emerging markets and developing countries playing a bigger and more active role in global governance in the future, State Councilor and Foreign Minister Wang Yi said at a news conference on Monday.

China looks forward to seeing emerging markets and developing countries playing a bigger and more active role in global governance in the future, State Councilor and Foreign Minister Wang Yi said at a news conference on Monday.

SOUTH SAN FRANCISCO, Calif., March 07, 2022 -- Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that the U.S. Food and... | March 7, 2022

Chinese State Councilor and Foreign Minister Wang Yi said on Saturday the Ukraine crisis can only be solved through dialogue and negotiations and stressed that China supports all efforts that help ease tensions and push for political solution, and opposes all actions that are not conducive to diplomatic resolution but add fuel to the fire.

WALTHAM, Mass., March 04, 2022 -- Morphic Therapeutic , a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today... | March 4, 2022

Developing innovative therapies for the treatment of respiratory diseases March 2022 Nasdaq: VRNA |... | March 3, 2022

Company is Scaling up Camelina Line E3902 Seed Production and Developing Herbicide Tolerant Lines Renewable Diesel for Transportation is Driving Demand for Vegetable Oil in the U.S. and... | March 3, 2022

HOUSTON, March 03, 2022 -- Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced... | March 3, 2022